Bluejay Therapeutics last raised $182.0M in its Later Stage VC (Series C) (May 2024).
- ·The complete investor list: 13 names
- ·Watch Bluejay Therapeutics: the Monday email on marks, rounds and moves
Bluejay Therapeutics funding history
3 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| May 2024 | Later Stage VC (Series C) | $182.0M | ▮ | ▮ |
| Aug 2022 | Early Stage VC | $20.5M | ▮ | ▮ |
| Jun 2021 | Early Stage VC | $19.2M | ▮ | ▮ |
Membership and data by Private Market View
Bluejay Therapeutics valuation
Bluejay Therapeutics's last known valuation is $820 million. The figure stands until a priced round, a secondary trade or an institutional fund mark prices the stock again.
How much has Bluejay Therapeutics raised?
Bluejay Therapeutics has raised $243 million across 3 recorded rounds since 2021. The largest was a $20.5 million early-stage round in Aug 2022; the most recent was an $182 million Series C in May 2024.
Bluejay Therapeutics has filed 3 Form Ds with the SEC since 2021, most recently in May 2024 ($182 million sold to 19 investors).
Comparable companies
Comparable drug discovery names by valuation on PrivateMarketView: Parabilis Medicines ($920 million), Abcuro ($700 million) and Candid Therapeutics ($657 million).
How Bluejay Therapeutics's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For Bluejay Therapeutics, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →
Frequently asked about Bluejay Therapeutics
- What is Bluejay Therapeutics worth?
- Bluejay Therapeutics's last known valuation is $820.0M.
- How much has Bluejay Therapeutics raised?
- Bluejay Therapeutics has raised $243.0M in total funding across 3 recorded rounds.
- When did Bluejay Therapeutics last raise?
- Bluejay Therapeutics last raised in May 2024 (Later Stage VC (Series C)), raising $182.0M.